Insulet Corp stock is traded at $148.55, with a volume of 476,706. It is down -0.84% in the last 24 hours and up +9.81% over the past month. Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Previous Close:
$149.81
Open:
$148.72
24h Volume:
476,706
Relative Volume:
0.33
Market Cap:
$10.31B
Revenue:
$2.90B
Net Income/Loss:
$302.80M
P/E Ratio:
34.57
EPS:
$4.30
Net Cash Flow:
$387.80M
1W Performance:
-4.07%
1M Performance:
+9.81%
6M Performance:
-3.64%
1Y Performance:
-53.63%
1-Day Range:
$145.94$149.27
1-Week Range:
$143.28$168.47
52-Week Range:
$126.40$354.88
Insulet Corp Stock (PODD) Company Profile
Name
Insulet CorpSector
HealthcareIndustry
Medical DevicesPhone
978-600-7000Address
100 NAGOG PARK, ACTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS